Articles

Stocks face earnings test with S&P 500 on pace for worst performance in a shutdown since 1990

Stocks are approaching a clear test after investors were left in the fog of a government shutdown this month and rattled by fresh tariff fears Friday.

A dividend-paying ‘vending machine’ — this oil stock weathers tariffs and OPEC

Charlie Garcia responds to readers about an underfollowed stock with a long history of rewarding shareholders.

If New York or California enter a recession, the entire U.S. economy would be next. So how are they doing?

As two of the biggest states in the country, their economies ”may be canaries in the coal mine,” one economist notes.

How can Anthropic stand out in the AI wars? I went to a Greenwich Village pop-up to find out.

Anthropic’s brand-awareness effort drew thousands as the company competes for consumer attention amid increasing competition.

‘I’m stumped’: I put $3,000 on my credit card during a vacation and my credit score plunged. Why is it so volatile?

“Doesn’t a 30-year history of good credit count for anything?”

Some of the largest exchanges and financial institutions are embracing betting platforms and crypto. Is it just for the fees?

If legacy financial institutions don’t embrace new technology, their competitors may leave them in the dust.

Crypto bulls were amped for potential solana ETF approvals this week. But the government shutdown threw it into limbo.

Crypto bulls have been buzzing with anticipation that several major Wall Street firms may win approval to launch exchange-traded funds investing in solana, a lesser-known crypto, as soon as this week, but a partial U.S. government shutdown has thrown the process into limbo.

Morgan Stanley is opening cryptocurrency investments to all clients. Here’s what percentage of your portfolio should be in crypto.

Morgan Stanley will rely on its automated monitoring processes to make sure clients are not overly exposed to crypto.

AstraZeneca to become latest drugmaker to strike deal with Trump. Its stock is down but outperforming the market.

AstraZeneca looks poised to announce a deal with U.S. President Donald Trump that’s focused on lowering drug prices, in a move that would see the British drugmaker follow in the footsteps of Pfizer.

What to expect in the stock market after a three-year bull run

Also: A threat to online sports-betting platforms, AI bubble fears, Medicare enrollment, and advice from the Moneyist

The price of silver is on track for a historic breakout. Why it has taken 45 years to get here.

On the heels of a fast and furious climb this year, silver is within sight of $50 an ounce — a level investors are eager to celebrate because it’s taken the white metal 45 years to get here.

Rocket Lab keeps winning launch deals, putting its stock on track for this milestone

The space-technology stock is on pace for its 10th day in a row of gains, which would make for its longest winning streak on record.
1 120 121 122 123 124 2,478